Temozolomide in combination with fotemustine in patients with metastatic melanoma


Tas F., Camlica H., Topuz E.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.62, sa.2, ss.293-298, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 62 Sayı: 2
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1007/s00280-007-0606-5
  • Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.293-298
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose Temozolomide and fotemustine are both active drugs for treating metastatic melanoma. The present study was designed to assess the efficacy and safety of combination therapy with temozolomide + fotemustine in patients with metastatic melanoma.